carbimazole has been researched along with Chronic Hepatitis C in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, PL; Chung, GB; Liu, CH; Wu, KD; Yang, WS | 1 |
| Entremont, A; Hautecouverture, M; Huet, D | 1 |
2 other study(ies) available for carbimazole and Chronic Hepatitis C
| Article | Year |
|---|---|
Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Antiviral Agents; Carbimazole; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Propranolol; Quadriplegia; Recombinant Proteins; Ribavirin; Thyroid Diseases; Time Factors; Treatment Outcome | 2008 |
[Basedow's disease and interferon for hepatitis C. Recurrence as Basedow's ophthalmopathy after interferon reintroduction].
Topics: Anti-Inflammatory Agents; Antithyroid Agents; Antiviral Agents; Autoimmunity; Carbimazole; Graves Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Methylprednisolone; Middle Aged; Recurrence; Time Factors | 2000 |